Egle Therapeutics
Tregs starving immunosuppressive cells
- B2B
About Egle Therapeutics
Development of innovative therapies focusing on starving immunosuppressive T-regulatory cells to modulate immune responses effectively.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2020
- Revenue
- Early-stage startupno revenue figure
- Website
- egle-tx.com
- linkedin.com/company/egle-tx
Egle Therapeutics at a glance
Egle Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Egle Therapeutics was founded in 2020.
Egle Therapeutics has 51–250 employees.
Frequently asked questions about Egle Therapeutics
How many employees does Egle Therapeutics have?
Egle Therapeutics has 51–250 employees.
Where is Egle Therapeutics headquartered?
Egle Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like Egle Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies